Herzfeld reports tender offer share transaction for fund
Erik Mervin Herzfeld reports a transaction involving nearly 5,000 shares of Herzfeld Credit Income Fund, reflecting ongoing activity in the investment fund sector.
G-III Apparel CEO Transfers 70,000 Shares to Family Trusts
Morris Goldfarb of G-III Apparel Group reports transferring 70,000 shares to family trusts, reflecting wealth management strategies in the apparel sector.
Rezolute CFO Daron Evans reports share transactions
Rezolute, Inc. CFO Daron Evans files share ownership changes, affecting family holdings and a managed entity, PoC Capital LLC.
Linda Rebrovick sells 12,000 shares of HealthStream Inc.
Linda Rebrovick has sold 12,000 shares of HealthStream Inc. as part of a trading plan, retaining 39,329 shares post-transaction.
Sharplink's CIO Matthew Sheffield Reports Stock Transaction
Matthew A. Sheffield, CIO of Sharplink, Inc., reports a stock transaction involving over 53,000 shares, reflecting his ongoing commitment to the company.
G-III Apparel Executive Reports Significant Stock Transaction
Jeffrey Goldfarb of G-III Apparel reported a major stock transaction involving a gift of shares to a trust, reflecting ownership changes in the apparel industry.
Paylor Ryan M reports tender offer transaction for shares
Ryan M. Paylor disclosed a transaction involving 490 shares of Herzfeld Credit Income Fund, reflecting ongoing investment strategies in asset management.
Herzfeld reports sale of shares in Herzfeld Credit Income Fund
Brigitta Suzanne Herzfeld sells 1,086 shares in Herzfeld Credit Income Fund, reflecting ongoing management of her investment holdings.
Palazzo Ryan Reports Sale of Shares in Centuri Holdings
Palazzo Ryan, President of U.S. Gas at Centuri Holdings, reports a sale of shares, reflecting ongoing executive engagement in the company.
Polk Dennis Reports Stock Transactions for TD SYNNEX Corp
Dennis Polk has reported stock transactions involving TD SYNNEX Corp, reflecting significant changes in his ownership stake.
Hall William Cadik Jr. reports stock transaction with Ally
Hall William Cadik Jr. reports a transaction involving 10,614 shares of Ally Financial stock, reflecting ongoing financial activity and executive accountability.
Slide Insurance Chief Risk Officer Executes Stock Transactions
Matthew Larson, Chief Risk Officer of Slide Insurance, executed stock options and sold shares, reflecting strategic financial management within the company.
Arcosa director reports stock transactions after merger deal
Arcosa, Inc. director John W. Lindsay reports stock transactions following the merger with CRH Americas, indicating strategic shifts in the company.
Narayanadas Vivek sells 1,021 shares of Oklo Inc. stock
Narayanadas Vivek, General Counsel of Oklo Inc., sold 1,021 shares of stock in a recent SEC filing, emphasizing transparency in the electric services sector.
Umberger Executes Major Share Transactions at Kestra Medical
Traci S. Umberger of Kestra Medical Technologies reports significant share transactions, reflecting strategic financial maneuvers in the medical instruments sector.
Silvia, Inc. CFO Renae Cormier Departs, Reports Stock Moves
Silvia, Inc. reports stock transactions after CFO Renae Cormier's departure, reflecting ongoing changes in the finance services sector.
Allogene Therapeutics CFO sells shares to cover tax obligations
Allogene Therapeutics CFO Geoffrey M. Parker sells shares to cover tax obligations, reflecting the company's equity incentive management strategy.
Invesco Advantage Municipal Income Trust II Reports Stock Changes
Invesco Advantage Municipal Income Trust II reveals stock transactions by Bank of America and Merrill Lynch, emphasizing activity in the financial sector.
Arcosa director disposes of shares amid merger with CRH Americas
Arcosa, Inc. reports a stock transaction by director Trent Melanie Montague as part of its merger with CRH Americas, impacting the fabricated metal products industry.
Pershing Edward Reports Ownership Changes in Provectus Biopharmaceuticals
Pershing Edward updates ownership stakes in Provectus Biopharmaceuticals, signaling potential shifts in company strategy and industry dynamics.